Wolverine Asset Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Wolverine Asset Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,508	Closed	-$1.45K	–	1843
2024 Q4	$1.45K	Sell	14,508 -13,345	-48%	-$681	﹤0.01%	1496
2024 Q3	$1.97K	Sell	27,853 -281	-1%	-$25	﹤0.01%	1481
2024 Q2	$2.45K	Buy	28,134 +5,687	+25%	+$595	﹤0.01%	1472
2024 Q1	$3.59K	Sell	22,447 -30,019	-57%	-$3.41K	﹤0.01%	1423
2023 Q4	$4.24K	Buy	+52,466	New	+$7.08K	﹤0.01%	1490

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Wolverine Asset Management's NKGNW Position: Q1 2025 in Review

Wolverine Asset Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 14,508 shares — an estimated $1.45K sold.

Wolverine Asset Management first reported a position in NKGNW in Q4 2023 and held it in 5 quarters. The position peaked at $4.24K in Q4 2023. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Wolverine Asset Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Wolverine Asset Management sold 14,508 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $1.45K.
Wolverine Asset Management first reported a position in NKGen Biotech, Inc. Warrants in Q4 2023 and held it in 5 quarters.
Wolverine Asset Management's NKGen Biotech, Inc. Warrants position peaked at $4.24K in Q4 2023.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Wolverine Asset Management's 13F filing for Q1 2025, filed 12 May 2025.